Related Experiment Video
Updated: Jan 10, 2026

Author Spotlight: Understanding and Detecting Environmental Antimicrobial Resistance by Combining Culture-Based Techniques and Genomics
Published on: July 19, 2024
Is mandatory surveillance of carbapenemase-producing Gram-negative organisms working? A surveillance evaluation,
Lucy Findlater1, Emily L Mason2, Jacquelyn McCormick2
1UK Field Epidemiology Training Programme, UK Health Security Agency, London, UK; Antimicrobial Resistance and Healthcare Associated Infections Division, Epidemic and Emerging Infections Directorate, UK Health Security Agency, London, UK.
Background:
Carbapenemase-producing organisms (CPOs) are an increasing public health threat. In October 2020, English laboratories were mandated to report acquired CPO detections in Gram-negative organisms from human clinical samples and screens to the existing national laboratory reporting system.
Aim:
The aim of this study was to describe acquired CPO epidemiology and evaluate the laboratory coverage, data quality, timeliness, simplicity and acceptability of the mandatory surveillance system.
Methods:
Using a mixed-method approach, we extracted laboratory-confirmed CPO reports from 1st October 2020 to 31st December 2023 to assess laboratory coverage (proportion of laboratories reporting at least one CPO to the Second Generation Surveillance System in 2023) and data quality (completeness of variables). We conducted semistructured interviews with stakeholders to assess simplicity, acceptability and perceived timeliness via thematic analysis.
Findings:
Reports of acquired CPO episodes in England doubled, from 2,670 (2021) to 5,759 (2023), with regional variation in rates (London: 21.3/100,000 population vs South-West: 1.8/100,000). In 2023, laboratory coverage was 72% (83/115), from 38 to 100% by region. Data quality was high. Participants (N = 12) described laboratory reporting delays due to technical issues, limited staff capacity or human error but were satisfied with the timeliness of surveillance outputs for monitoring longer-term trends. Mandatory reporting was acceptable, and some participants experienced streamlined, automated reporting, whereas others noted complicated or manual workarounds using pre-existing systems.
Conclusions:
Reported CPO incidence is increasing, and CPO surveillance is perceived as efficient, valuable and acceptable. However, despite being mandatory, laboratory reporting is still not comprehensive. We recommend investing in improvements to the existing surveillance system, ensuring that all laboratories have capacity to report and optimise processes.
More Related Videos
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Related Concept Videos
Antimicrobial Effectiveness
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Development of Antibiotic Resistance